Last reviewed · How we verify
Home-based Biofeedback for the Prevention of Migraine (BioCer)
The goal of this clinical trial is to test an app-based biofeedback treatment in adults with migraine. The aim of the study is to investigate the safety and effectiveness of biofeedback treatment using the medical device Cerebri, compared to wait-list controls. Participants will perform 10 minutes biofeedback daily, in addition to daily registrations in the headache diary. Wait-list controls will complete daily registrations in the headache diary during the same period. Researchers will compare the reduction in the number of days with migraine from baseline per 28-day period between treatment group and the wait-list group.
Details
| Lead sponsor | Nordic Brain Tech AS |
|---|---|
| Phase | NA |
| Status | COMPLETED |
| Enrolment | 279 |
| Start date | Sun Jan 01 2023 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Mon Sep 23 2024 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Migraine
Interventions
- Cerebri biofeedback
- Cerebri headache diary
Countries
Norway